SRp30c Activators
SRp30c Activators are compounds that influence cellular signaling pathways or phosphorylation states to facilitate the enhancement of SRp30c's role in RNA splicing. Forskolin, by increasing cAMP levels, indirectly supports PKA activation, which can enhance SRp30c activity through altered phosphorylation. Similarly, 5-Iodotubercidin elevates adenosine levels, potentially allowing for more effective PKA-mediated modulation of SRp30c. SRp30c Activators are compounds that influence cellular signaling pathways or phosphorylation states to facilitate the enhancement of SRp30c's role in RNA splicing. Forskolin, by increasing cAMP levels, indirectly supports PKA activation, which can enhance SRp30c activity through altered phosphorylation. Similarly, 5-Iodotubercidin elevates adenosine levels, potentially allowing for more effective PKA-mediated modulation of SRp30c. These activators would be designed to modulate the activity of SRp30c, which is a part of the serine/arginine-rich (SR) family of proteins.
This protein family is known to be integral to the splicing of pre-mRNA, influencing the excision of introns and the fusion of exons to generate mature messenger RNA (mRNA) molecules. Activators of SRp30c would, therefore, be molecules that can enhance the function of this protein, possibly by stabilizing its active form, promoting its interaction with other components of the spliceosome, or by facilitating its recruitment to pre-mRNA substrates.
The function of such activators could extend to the modulation of alternative splicing events. Since SRp30c can determine which exons are included or excluded during the splicing process, activators could influence the generation of different mRNA isoforms from a single gene. This would affect the diversity of proteins that can be produced. By enhancing SRp30c activity, these molecules could ensure a higher efficacy of splicing events, possibly affecting the abundance and variety of proteins within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, which in turn activates PKA. PKA phosphorylation can modulate splicing factor dynamics, potentially affecting SRp30c activity by altering its phosphorylation state, thus indirectly enhancing its splicing activity. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $153.00 $464.00 | 20 | |
5-Iodotubercidin is an adenosine kinase inhibitor that increases intracellular adenosine levels, affecting adenosine receptors and downstream PKA activity. This can influence the phosphorylation and function of splicing factors like SRp30c. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid, a protein phosphatase inhibitor, specifically inhibits PP1 and PP2A, leading to increased phosphorylation levels of splicing factors, which could enhance SRp30c function in RNA splicing by maintaining its phosphorylated, active form. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin 1 activates PKC which can influence the phosphorylation state of splicing factors. Through this mechanism, Bryostatin 1 could enhance SRp30c's role in spliceosome assembly and function. | ||||||
Indirubin-3′-monoxime | 160807-49-8 | sc-202660 sc-202660A sc-202660B | 1 mg 5 mg 50 mg | $79.00 $321.00 $671.00 | 1 | |
Indirubin-3'-monoxime is a cyclin-dependent kinase inhibitor that can modulate cell cycle progression. Through inhibition of CDKs, it can potentially affect the cell cycle-dependent phosphorylation of splicing factors, thereby influencing SRp30c function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits several kinases, potentially reducing competitive phosphorylation events and thereby allowing kinases that phosphorylate SRp30c to act more effectively, indirectly enhancing its splicing activity. | ||||||
Spermidine | 124-20-9 | sc-215900 sc-215900B sc-215900A | 1 g 25 g 5 g | $57.00 $607.00 $176.00 | ||
Spermidine induces hypusination of eukaryotic initiation factor 5A (eIF5A), which is involved in mRNA turnover and splicing. This can indirectly enhance SRp30c activity by modulating the splicing machinery's composition and function. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cAMP analog that activates PKA. PKA can modulate the phosphorylation state of splicing factors, including SRp30c, thereby potentially enhancing its activity in the splicing process. | ||||||
Harmine | 442-51-3 | sc-202644 sc-202644A sc-202644B sc-202644C sc-202644D sc-202644E sc-202644F | 250 mg 500 mg 1 g 10 g 50 g 100 g 500 g | $53.00 $104.00 $126.00 $551.00 $1467.00 $2611.00 $11455.00 | 2 | |
Harmine is a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) inhibitor. By inhibiting DYRK, it could modify the phosphorylation state of SRp30c or its associated factors, which might enhance SRp30c's role in alternative splicing. | ||||||